Gilead Sciences, Inc.
Combination formulation of three antiviral compounds

Last updated:

Abstract:

Disclosed are pharmaceutical compositions comprising three antiviral compounds. In particular, the pharmaceutical compositions comprise an effective amount of velpatasvir, an effective amount of sofosbuvir, and an effective amount of voxilaprevir. Also disclosed are methods of use for the pharmaceutical composition.

Status:
Grant
Type:

Utility

Filling date:

1 Jun 2017

Issue date:

24 May 2022